Hepatology SJR and Scopus Metrics: What the Numbers Actually Tell Authors
Hepatology's Scopus profile confirms that it remains one of the defining journals in liver research, but the real submission question is whether the paper has true liver-specific consequence.
Next step
Choose the next useful decision step first.
Use the guide or checklist that matches this page's intent before you ask for a manuscript-level diagnostic.
Hepatology at a glance
Key metrics to place the journal before deciding whether it fits your manuscript and career goals.
What makes this journal worth targeting
- IF 15.8 puts Hepatology in a visible tier — citations from papers here carry real weight.
- Scope specificity matters more than impact factor for most manuscript decisions.
- Acceptance rate of ~~15% means fit determines most outcomes.
When to look elsewhere
- When your paper sits at the edge of the journal's stated scope — borderline fit rarely improves after submission.
- If timeline matters: Hepatology takes ~30 days median. A faster-turnaround journal may suit a grant or job deadline better.
- If open access is required by your funder, verify the journal's OA agreements before submitting.
Quick answer: Hepatology still has a top-end specialist profile in liver research. Current Scopus-linked sources place it at SJR 5.557, impact score 9.55, rank 243, and h-index 415 in 2024. That is strong enough to confirm real field authority. The actual submission question is whether the manuscript has clear liver-specific consequence and translational weight rather than simply touching the liver field.
Direct answer
If you want the short metric read, it is positive and stable.
Metric | Current value | What it tells you |
|---|---|---|
SJR | 5.557 | prestige-weighted influence remains very strong |
Impact Score | 9.55 | citation density is high for a specialist clinical-translational title |
Global rank | 243 | the journal sits comfortably in the upper specialist tier |
h-index | 415 | the archive has deep long-run liver-field authority |
Best quartile | Q1 | the title remains top quartile in its categories |
Coverage history | 1981-2025 | this is durable standing, not a short spike |
That profile says Hepatology is still one of the journals that define the liver field rather than merely participate in it.
Overview
The useful summary is that Hepatology works when the paper clearly belongs to hepatology as a field, not just to general organ biology or a broader GI audience.
What changed in 2024
The 2024 picture is a strengthening year.
- SJR moved up from 5.011 in 2023 to 5.557 in 2024
- impact score moved up from 7.92 to 9.55
- global rank improved from 282 to 243
That is a meaningful move, not noise. The journal entered 2024 stronger on both prestige weighting and citation density than it was one year earlier.
Ten-year SJR and Scopus trend
Year | SJR | Impact Score | Global Rank |
|---|---|---|---|
2024 | 5.557 | 9.55 | 243 |
2023 | 5.011 | 7.92 | 282 |
2022 | 4.152 | 8.89 | 358 |
2021 | 5.235 | 9.42 | 241 |
2020 | 5.488 | 9.41 | 250 |
2019 | 5.377 | 8.08 | 255 |
2018 | 5.096 | 6.99 | 282 |
2017 | 5.541 | 7.22 | 246 |
2016 | 5.229 | 8.12 | 259 |
2015 | 4.879 | 8.08 | 294 |
2014 | 5.155 | 8.04 | 268 |
The pattern here is steadier than in some other specialties. Hepatology has largely lived in a narrow high-end SJR band for a decade, with a 2022 dip and a 2024 recovery. That is what a durable owner journal looks like. It does not need dramatic spikes to remain central.
What the trend means in practice
For authors, the trend usually means:
- the journal still carries real weight inside liver medicine and liver biology
- the title did not lose standing during the broader citation correction
- wrong-fit manuscripts are more likely to be exposed because the field still treats the venue seriously
The important nuance is that a stable specialist flagship is often harsher on fit than a broad journal with similar raw numbers. Readers know what a Hepatology paper is supposed to look like.
How Hepatology compares with nearby liver journals
Journal | 2024 SJR | What the metric profile usually signals |
|---|---|---|
Hepatology | 5.557 | owner journal for top-end liver-focused work |
Clinical and Molecular Hepatology | 3.635 | strong modern hepatology venue with narrower prestige reach |
JHEP Reports | 3.525 | strong open-access liver journal with a slightly lighter prestige signal |
This comparison is useful because it separates "good liver journal" from "top owner journal." Hepatology still sits clearly above two strong alternatives that many papers would fit honestly.
What editors are really screening for
The official scope language keeps the journal centered on liver structure, function, and disease, with emphasis across viral hepatitis, cirrhosis, liver cancer, metabolic liver disease, immunology, and drug metabolism. In practice, editors are usually screening for:
- unmistakable liver-specific consequence
- a paper that matters to hepatologists, not only to a neighboring discipline
- enough mechanistic or translational depth to justify a flagship liver audience
- evidence strong enough that the claim will travel through the field
That is why a paper can be impressive and still not feel like Hepatology. The journal is selective about field ownership, not just technical quality.
In Our Pre-Submission Review Work on Hepatology Metric Questions
In our pre-submission review work on Hepatology metric questions, three mistakes appear often.
The liver-wrapper mistake. Authors sometimes present a broader immunology, oncology, or metabolism paper with a liver framing added late. The metrics do not save that kind of fit problem.
The GI-versus-liver mistake. Another common miss is work that belongs more naturally in a broader GI journal or a different specialty owner journal. Strong numbers do not tell you which owner community will claim the paper.
The translational-gap mistake. We also see manuscripts with good liver biology but incomplete clinical or translational consequence. At this level, editors often want more than a signal that the topic is relevant.
That is what the metrics actually explain. The title is strong enough that the journal does not need to take near-fit papers.
What these metrics mean for authors
For authors, the current profile says:
- Hepatology remains one of the strongest pure liver destinations
- papers published there are still highly legible to the field
- the bar is about liver consequence, not just general biomedical quality
- a manuscript can be very good and still belong in a different specialty venue
The h-index of 415 reinforces that this is a long-memory field journal. New papers are judged against decades of core liver literature.
Submit If / Think Twice If
Submit if:
- the paper has obvious liver-specific consequence
- the manuscript combines strong evidence with clear hepatology relevance
- the work will matter to clinicians and translational researchers in liver disease
- the field identity of the paper is clearly hepatology rather than generic GI or metabolism
Think twice if:
- the liver framing feels added on rather than central
- the manuscript is better interpreted as broader GI or immunology work
- the translational or disease consequence is still too soft
- another liver journal would fit the scope more honestly with less prestige mismatch
Readiness check
Run the scan while the topic is in front of you.
See score, top issues, and journal-fit signals before you submit.
What should drive the submission decision instead
The better question is whether the manuscript is truly a Hepatology paper.
That is why the better next reads are:
- Hepatology acceptance rate
- Hepatology impact factor
- Hepatology journal profile
- Journal of Hepatology journal profile
If the paper has real liver-specific consequence, translational weight, and strong validation, the metrics support the risk. If it is still generic organ-biology work with a liver wrapper, the same metrics are warning you not to force the fit. A Hepatology submission framing check is the fastest way to pressure-test that before submission.
Practical verdict
Hepatology has a strong Scopus-style profile and remains a rational top-end target for papers that truly matter to the liver field. The 2024 metrics are better than the 2023 ones, which makes the current signal more rather than less serious.
For authors, that means the number is confirming journal strength, not solving journal fit.
Frequently asked questions
Current metric sources report a 2024 SJR of 5.557 for Hepatology.
Current metric sources report a 2024 CiteScore of 29.7 for Hepatology.
Yes. Hepatology's Scopus profile and impact-factor range both place it among the strongest specialist liver journals in the world.
No. The real question is whether the manuscript delivers liver-specific consequence, translational relevance, and enough validation for this room.
Sources
- 1. Hepatology metrics page, Resurchify.
- 2. Hepatology author guidelines, Wiley / AASLD.
- 3. Top journals in Hepatology, Resurchify.
- 4. Hepatology journal page, Wiley / AASLD.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Start here
Same journal, next question
Supporting reads
Conversion step
Choose the next useful decision step first.
Use the scan once the manuscript and target journal are concrete enough to evaluate.